GlassScriptPhysician profile
Jeffrey E Askew
NPI 1295782746
$1,549.93
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $170 · 2021: $184 · 2022: $314 · 2023: $72.05 · 2024: $15.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $191.22 | 2019-2021 | |
| Amgen INC. | $127.00 | 2019-2022 | |
| Akcea Therapeutics, INC. | $126.39 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $102.89 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $99.55 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $72.60 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.99 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $62.89 | 2019-2022 | |
| Abbott Laboratories | $61.85 | 2019 | |
| Boston Scientific Corporation | $56.98 | 2019-2024 | |
| Portola Pharmaceuticals, LLC | $53.05 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.10 | 2019 | |
| Pfizer INC. | $48.89 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $45.60 | 2022-2023 | Camzyos |
| Impulse Dynamics (USA) INC. | $44.07 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $38.94 | 2022 | |
| Medicomp INC | $38.19 | 2022 | |
| Medtronic, INC. | $30.83 | 2021-2023 | Micra |
| Merck Sharp & Dohme LLC | $29.62 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.83 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $23.07 | 2019-2021 | |
| United Therapeutics Corporation | $22.41 | 2019 | |
| Esperion Therapeutics, INC. | $15.58 | 2021 | |
| Amarin Pharma, INC. | $15.27 | 2020 | |
| Allergan, INC. | $15.10 | 2019 | |
| Nuwellis, INC. | $14.66 | 2019 | |
| Medtronic Vascular, INC. | $14.27 | 2019 | |
| B. Braun Interventional Systems INC. | $13.98 | 2019 | |
| Philips North America LLC | $12.76 | 2022 | |
| Itamar Medical INC | $11.34 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Askew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.